Treatment of psoriatic skin lesions with a new Er:Yag laser technology: A case series study
- PMID: 32096324
- DOI: 10.1111/dth.13264
Treatment of psoriatic skin lesions with a new Er:Yag laser technology: A case series study
Abstract
Erbium: YAG (Er:YAG) laser with RecoSMA technology. This laser emits thousands of microbeams of energy causing superficial epidermal ablation and a separation of dermal fibers due to a mechanical-acoustic and resonance effect. The aim of this study is to evaluate the clinical efficacy of Erbium: YAG (Er:YAG) laser with RecoSMA in the treatment of stable psoriasis vulgaris lesions. A questionnaire completed by 112 patients enrolled in the study. Photographs taken before each session, the analysis of the dynamics index PASI and histological studies were analyzed to visually monitor the clinical progress. The analyses were carried out with the help of computer software. The results after treatment of average number of sessions per course showed the complete clinical remission of the skin lesions in over 87% of the patients treated. The Er:YAG laser and RecoSMA have demonstrated the high effectiveness of the laser method of treating skin manifestations of the disease and improving the quality of life of patients.
Keywords: Er:YAG; PASI index; RecoSMA technology; laser; mechanical-acoustic effect; psoriasis vulgaris; space-modulated ablation.
© 2020 Wiley Periodicals, Inc.
Similar articles
-
Treatment of Chronic Lower Extremity Ulcers with A New Er:Yag Laser Technology.Laser Ther. 2017 Sep 30;26(3):211-222. doi: 10.5978/islsm.17-OR-17. Laser Ther. 2017. PMID: 29133969 Free PMC article.
-
Spatially modulated erbium YAG laser as a treatment for diabetic ulcer.J Wound Care. 2023 Oct 1;32(Sup10a):S21-S29. doi: 10.12968/jowc.2023.32.Sup10a.S21. J Wound Care. 2023. PMID: 37830841
-
Clinical benefit of using a multifractional Er:YAG laser combined with a spatially modulated ablative (SMA) module for the treatment of striae distensae: A prospective pilot study in 20 patients.Lasers Surg Med. 2019 Mar;51(3):230-238. doi: 10.1002/lsm.23042. Epub 2018 Nov 27. Lasers Surg Med. 2019. PMID: 30480320 Clinical Trial.
-
Delivery of light to the skin through ablated conduits.Lasers Surg Med. 2017 Jan;49(1):69-77. doi: 10.1002/lsm.22533. Epub 2016 May 19. Lasers Surg Med. 2017. PMID: 27197620 Review.
-
Modulating the Er:YAG laser.Lasers Surg Med. 2000;26(2):223-6. doi: 10.1002/(sici)1096-9101(2000)26:2<223::aid-lsm14>3.0.co;2-k. Lasers Surg Med. 2000. PMID: 10685096 Review.
Cited by
-
VISIA Skin Analysis System as a Tool to Evaluate the Reduction of Pigmented Skin and Vascular Lesions Using the 532 Nm Laser.Clin Cosmet Investig Dermatol. 2022 Oct 14;15:2187-2195. doi: 10.2147/CCID.S380388. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36267688 Free PMC article.
References
REFERENCES
-
- Alcolea, J. M., Hernández, E., Martínez-Carpio, P. A., Vélez, M., Khomchenko, V., Sola, A., & Trelles, M. A. (2017). Treatment of chronic lower extremity ulcers with a new Er:Yag laser technology. Laser Therapy, 23(6), 211-222.
-
- Alora, M. B. T., Anderson, R. R., Quinn, T. R., & Taylor, C. R. (1998). CO2 laser resurfacing of psoriatic plaques: A pilot study. Lasers in Surgery and Medicine, 22(3), 165-170.
-
- Bekassy, Z., & Astedt, B. (1986). Carbon dioxide laser vaporization of plaque psoriasis. British Journal of Dermatology, 114(4), 489-492.
-
- Damevska, K., França, K., Lotti, T., Nikolovska, S., & Pollozhani, N. (2018). Complementary and integrative therapies for psoriasis: Looking forward. Dermatologic Therapy, 31, e12627. https://doi.org/10.1111/dth.12627
-
- Drew, G. S. (2000). Psoriasis. Primitive Care, 23(2), 385-406.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical